The FTSE 100 is up 0.1 per cent in early trading. Among the companies with reports and trading updates today are AstraZeneca, Lok’nstore, Darktrace, M&C Saatchi and Mears. Read the Thursday 11 April Business Live blog below.

> If you are using our app or a third-party site click here to read Business Live

Market update: FTSE 100 flat; FTSE 250 flat

London-listed stocks are treading water in early trading as investors shift their focus from yesterday’s hotter-than-expected US inflation data to the European Central Bank’s interest rate decision later today.

Industrial metal miners have added 1 per cent as copper prices tick higher, supported by firm market fundamentals and a retreat in the US dollar.

Markets expect the ECB to maintain its current peak borrowing costs in its monetary policy meeting later in the day, though it could signal that an interest rate cut is coming as soon as June.

Among individual stocks, Darktrace has surged 8.8 per cent after the cybersecurity company raised its annual revenue and margin forecasts for the third time this year.

Lok’NStore has jumped 16.9 per cent after rival Shurgard agreed to acquire the self-storage company in a deal valued at £378million.

AstraZeneca hikes dividend as investors vote on chief executive’s pay

AstraZeneca has hiked its annual dividend by 7 per cent to $3.10 per share, as the London-listed drugmaker bets on its blockbuster cancer drugs to deliver strong performance and cash generation.

The dividend boost comes as shareholders gear up to vote on the firm’s chief executive’s controversial bumper pay package at its annual general meeting later on Thursday.

Chair Michel Demaré, said: ‘This uplift is in line with our progressive dividend policy, which remains unchanged, and reflects the continuing strength of AstraZeneca’s investment proposition for shareholders.’

FTSE 100 currently up 1.96 points to 7,963.17

And the FTSE 250 is up 2.61 points to 19,804.36.

ECB set to keep eurozone interest rates unchanged today

Joost van Leenders, senior investment strategist at Van Lanschot Kempen:

‘We expect a relatively uneventful ECB meeting today, with the ECB leaving interest rates unchanged.

‘The ECB has clearly signaled that it wants to see more evidence of moderating wage growth before it is ready to cut interest rates. With this in mind, it expects to have enough evidence by the June meeting, so a first cut by then is still the most likely scenario for us.

‘ECB President Lagarde will surely get questions about the disappointing US inflation numbers for March, which make a Fed cut in June unlikely, but she will point out that the ECB is focused only on the eurozone.

‘More interesting will be what the ECB has to say about inflation in the eurozone. According to the seasonally adjusted CPI the ECB publishes, core inflation has accelerated this year – yet another reason to keep rates unchanged at this meeting and wait until June to see how this will develop.’

Darktrace lifts guidance as revenues soar

Darktrace has boosted its annual revenue and margin forecasts for the third time this year after the British cybersecurity company’s third-quarter revenue jumped nearly 27 per cent.

The London-listed firm has benefited from demand for its services due to an increase in digital attacks, as well as the artificial intelligence boom. It expects revenue from new customers to grow as the economic environment begins to improve.

‘We believe the markets in which we operate are emerging from a period of relative economic uncertainty and moving to an environment where organisations can prioritise proactive cyber defense,’ Chief financial officer Cathy Graham said.

Accounting giant KPMG fined £20m after senior partners and managers cheat in exams

Accounting giant KPMG received the biggest fine ever handed out by the US audit watchdog after senior partners and managers cheated on professional exams.

The Big Four’s Dutch division was fined £20million after hundreds of its staff were found to have improperly shared answers in mandatory training courses between 2017 and 2022.

Shurgard set to buy Lok’nstore for £378m

European self-storage company Shurgard has agreed to buy UK-listed rival Lok’nStore in a deal worth £378million.

Shurgard has agreed to spend £11.10 in cash for each Lok’n Store share, which it said represents a 15.9 per cent premium to the London-listed firm’s closing price on 10 April.

Andrew Jacobs, chair of Lok’nStore, said:

‘Lok’nStore’s board believes the offer represents significant value for Lok’nStore’s shareholders, recognising the quality of Lok’nStore’s real estate portfolio and operational strength.

Over the years Lok’nStore has built a unique portfolio of purpose-built self-storage assets.

‘We believe that integrating Lok’nStore’s assets and operations into Shurgard is highly complementary considering Lok’nStore’s asset locations and positioning in its markets.

‘I would like to take the opportunity to highlight the contribution of Lok’nStore’s team over the years, whose commitment has enabled building the business to its high standards and unique asset quality it is recognised for today and ensuring leading positioning in the markets in which it operates.’

US inflation shock dents rate cut hopes: Borrowing costs soar in market turmoil

Interest rate cut hopes faded on both sides of the Atlantic yesterday after US inflation rose to a higher-than-expected 3.5 per cent.

The figures wreaked havoc on financial markets as bond yields soared, Wall Street stocks tumbled, and the pound fell sharply.

Paul Ashworth, chief North America economist at Capital Economics, said that the data ‘pretty much kills off hopes of a June rate cut’ from the Federal Reserve.

AstraZeneca hikes dividend

AstraZeneca has hiked its annual dividend by 7 per cent to $3.10 per share, as the London-listed drugmaker bets on its blockbuster cancer drugs to deliver strong performance and cash generation.

The Anglo-Swedish pharma firm said it expects total revenue and core earnings per share to increase by percentages in the low double-digits to low-teens this year

‘This uplift is in line with our progressive dividend policy, which remains unchanged, and reflects the continuing strength of AstraZeneca’s investment proposition for shareholders,’ Chair Michel Demaré said.

Read More: World News | Entertainment News | Celeb News
Mail Online

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Saudi Arabia’s Aramco halts plans to increase maximum oil production capacity

Valvoline had last year decided to separate its retail services and global…

Cramer: Earnings take center stage this week, but don’t sleep on the Fed and Treasury

We’ve been relatively free of actions by the Treasury and the Federal…

Super Micro plunges as investors rotate out of red-hot AI stock ahead of earnings later this month

David Paul Morris | Bloomberg | Getty Images Super Micro Computer shares…

Senate passes long-awaited aid for Israel, Ukraine, Taiwan, and TikTok bill

U.S. Senate Majority Leader Chuck Schumer (D-NY) speaks to the media after…